Genprex Inc. (NASDAQ:GNPX) does about 1.79M shares in volume on a normal day but saw 3369725 shares change hands in Tuesday trading. The company now has a market cap of 157.12M USD and an enterprise value of about $130.25M. Its current market price is $4.00, marking an increase of 1.01% compared to the previous close of $3.96. The 52 week high reached by this stock is $7.03 whilst the lowest price level in 52 weeks is $0.23. The script in recent trading has seen the stock touch a high of $4.47 and a low of $3.88.
Genprex Inc. (GNPX) has a 20-day trading average at $3.85 and the current price is -43.10% off the 52-week high compared with 1631.60% distance from its 52-week low. The 50-day simple moving average of the closing price is $3.53 and its 200-day simple moving average is $2.43. If we look at the stock’s price movements over the week, volatility stands at 8.27%, which increases to 9.02% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 56.70 to suggest the stock is neutral.
FactSet Research has provided data showing that 1 brokerages have issued ratings for the stock. 0 analysts have rated it as a sell, while 0 advise that it is a overweight. 1 analysts have rated it as a buy and 0 have advised that investors hold their positions. The consensus recommendation rating is Buy and Wall Street’s advice is for investors to Moderate Buy the stock.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on April 29, 2019 when Noble Capital Markets initiated the stock to “Outperform” and issued a price target of $5.
The current price level is 4.43%, 13.82%, and 65.75% away from its SMA20, SMA50, and SMA200 respectively, with the GNPX price moving below the 50-day SMA on September 01. Genprex Inc. (GNPX) stock is down -2.91% over the week and 7.82% over the past month. Its price is 1150.00% year-to-date and 365.93% over the past year.
The stock last released its quarterly earnings report for quarter ended 6/29/2020, with the company’s earnings per share (EPS) of -$0.12 above consensus estimates by $0.01.
Its 12-month price target is $7.00. Of course, the average price target is just what the average analysts believe a stock will be worth in the next 52 weeks, and is only one metric. There are analysts with lower targets than the average, including one bearish Wall Street research firm advocating investors to wait for the price to pull back to $7.00, given the recent momentum. And then, on the bullish side of things, one analyst is expecting the stock to peak at $7.00.
Outstanding shares total 35.36M with insiders holding 23.00% of the shares and institutional holders owning 12.82% of the company’s common stock. The company has a return on equity of -107.20%. The forward price to earnings ratio is 16.00. Price to book ratio is 5.80.
According to a U.S. Securities and Exchange Commission filing, iShares Russell 2000 ETF has reduced its position in Genprex Inc. (GNPX) to 602,115 shares, mirroring a recent drop by -4.46%. iShares Russell 2000 ETF dumped 28084.0 shares of Genprex Inc. common stock bringing its total worth to about $2.03 million at the end of recent close, SEC documents show. iShares Russell 2000 ETF isn’t the only investment manager who changed stakes and is followed by Vanguard Extended Market Index Fu, which sold off 0.0 shares to end up with 293,690 shares worth $0.99 million. iShares Russell 2000 Growth ETF cut their holdings by -0.97% in the company over the course of the most recent quarter. It now holds a 0.68% position in Genprex Inc. thanks to 0.26 million shares amounting to $0.89 million.